These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23941331)

  • 1. The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy.
    Vashi PG; Gupta D; Lammersfeld CA; Braun DP; Popiel B; Misra S; Brown KC
    Nutr J; 2013 Aug; 12():118. PubMed ID: 23941331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Nutrition Status and Postoperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Reece L; Dragicevich H; Lewis C; Rothwell C; Fisher OM; Carey S; Alzahrani NA; Liauw W; Morris DL
    Ann Surg Oncol; 2019 Aug; 26(8):2622-2630. PubMed ID: 31123932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative nutritional assessment and interventions in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): A systematic review.
    Gearing PF; Hawke JA; Mohan H; Heriot AG; Khan A; Beaumont A; Laing E; Waters PS
    Eur J Surg Oncol; 2023 May; 49(5):902-917. PubMed ID: 36872111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral nutrition after cytoreductive surgery for peritoneal malignancy: Should it be administered routinely?
    Khan A; Beaumont A; Laing E; Guerra G; Jain A; Warrier S; Heriot A
    Clin Nutr ESPEN; 2023 Oct; 57():487-493. PubMed ID: 37739696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing cytoreductive surgery: a retrospective study.
    AlTawil E; Kalagi NA; Alzahrani S; Alobeed F; Alshammari S; Bin Traiki T
    Front Nutr; 2024; 11():1364959. PubMed ID: 38765813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
    Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
    World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of subjective global assessment and clinical outcomes in critically ill geriatric patients receiving nutrition support.
    Atalay BG; Yagmur C; Nursal TZ; Atalay H; Noyan T
    JPEN J Parenter Enteral Nutr; 2008; 32(4):454-9. PubMed ID: 18596319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
    Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V
    Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of preoperative nutritional status on the outcomes of an enhanced recovery after surgery (ERAS) programme for colorectal cancer surgery.
    Lohsiriwat V
    Tech Coloproctol; 2014 Nov; 18(11):1075-80. PubMed ID: 25216721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decline in nutritional status is associated with prolonged length of stay in hospitalized patients admitted for 7 days or more: A prospective cohort study.
    Allard JP; Keller H; Jeejeebhoy KN; Laporte M; Duerksen DR; Gramlich L; Payette H; Bernier P; Davidson B; Teterina A; Lou W
    Clin Nutr; 2016 Feb; 35(1):144-152. PubMed ID: 25660316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Factors Influencing Infectious Complications after Cytoreductive Surgery and HIPEC: Results from a Tertiary Referral Center.
    Cardi M; Sibio S; Di Marzo F; Lefoche F; d'Agostino C; Fonsi GB; La Torre G; Carbonari L; Sammartino P
    Gastroenterol Res Pract; 2019; 2019():2824073. PubMed ID: 31191642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidural analgesia combined with a comprehensive physiotherapy program after Cytoreductive Surgery and HIPEC is associated with enhanced post-operative recovery and reduces intensive care unit stay: A retrospective study of 124 patients.
    Osseis M; Weyrech J; Gayat E; Dagois S; Lo Dico R; Pocard M; Eveno C
    Eur J Surg Oncol; 2016 Dec; 42(12):1938-1943. PubMed ID: 27381171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Survival of Patients with Synchronous Colorectal Peritoneal Metastases Receiving Preoperative Chemotherapy Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Devilee RA; Simkens GA; van Oudheusden TR; Rutten HJ; Creemers GJ; Ten Tije AJ; de Hingh IH
    Ann Surg Oncol; 2016 Sep; 23(9):2841-8. PubMed ID: 27044447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
    Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
    World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
    Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
    J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of improved nutritional status on survival in ovarian cancer.
    Gupta D; Lis CG; Vashi PG; Lammersfeld CA
    Support Care Cancer; 2010 Mar; 18(3):373-81. PubMed ID: 19484479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.
    Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E
    Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Birgisson H; Enblad M; Artursson S; Ghanipour L; Cashin P; Graf W
    Eur J Surg Oncol; 2020 Dec; 46(12):2283-2291. PubMed ID: 32873455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.
    Valle SJ; Alzahrani N; Alzahrani S; Traiki TB; Liauw W; Morris DL
    Surg Oncol; 2016 Sep; 25(3):315-20. PubMed ID: 27566038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.